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“MANAGEMENT OF POSTERIOR CAPSULAR TEAR WITH 
SCLERAL FIXATION LENSES " 
1. INTRODUCTION 
Aphakia was once considered a complication of cataract surgery. The 
crystalline lens is responsible for approximately 30 percent of the total ocular 
dioptric power; removal of the lens therefore results in marked visual disability. 
The goal of effective rehabilitation after cataract extraction is a timely return to 
maximal visual function, including clear central and peripheral vision, stereopsis 
when possible, and comfort.1 
The development of safe, effective IOLs to eliminate the optical problem 
of aphakia is one of the great successes of modern ophthalmology. Whereas early 
lens designs and fixation sites were associated with an unacceptably high rate of 
complications, 2, 3. modern posterior chamber IOLs have a track record of 
remarkable safety and provide excellent visual outcome after insertion into the 
capsular bag or sulcus after uncomplicated cataract surgery.  In the presence of a 
posterior capsule tear during cataract extraction, the intraocular lens (IOL) can be 
placed in the sulcus if the capsular rim is available or in the bag if the tear is 
small. 
  When the posterior capsule tear is large or the capsular rim is unstable, 
scleral fixated intraocular lenses (SFIOL) or anterior chamber intraocular lenses 
(ACIOL) can be implanted. There are certain  advantages of SFIOL over ACIOL 
such as less corneal endothelial damage, minimising aniseikonia in contralateral 
eyes that are phakic or pseudophakic with a posterior chamber IOL in place.4-7  
Theoretical advantage of their use relate to a perceived better safety profile over 
anterior chamber intraocular lenses (AC-IOL) in regard to complications such as 
corneal endothelial compromise, peripheral anterior synechia and glaucoma. 
These issues are particularly relevant as the population group on whom this type 
of surgery is undertaken are often young (for example, ectopia lentis in Marfan 
syndrome) or have a history of prior ocular trauma, and consequently sutured PC-
IOLs are considered by many the procedure of choice in these patients.8 
2. REVIEW OF LITERATURE 
Secondary intraocular lens implantation as defined by Azar is insertion of an 
IOL into an eye which has been rendered aphakic by prior cataract extraction by any 
method, or by an exchange of IOL, which is a special case of secondary IOL 
implantation. 
TYPES OF SECONDARY IMPLANTS 
Secondary implants are of following types:-  
1. Secondary PCIOL, where PC is intact totally or partially following planned 
ECCE. 
2. Secondary ACIOL, after planned ICCE irrespective of vitreous face in 
patients above the age of 50. 
3. Scleral fixation IOL where ACIOL can’t be implanted or deferred to avoid 
corneal endothelial damage. 
INDICATIONS FOR SECONDARY IOL IMPLANTATION 
l. Monocular aphakia 
a) Spectacle or contact lens intolerance. 
b) Old disabled patients with tremor, Parkinsonism and other physical disability 
which makes handling and using of spectacle or contact lens difficult. 
c) Occupational and circumstantial situations where spectacle or contact lens is 
not suitable, like athletes, dancers, etc… 
 
2. Contralateral pseudophakia 
a) Aborted primary IOL implantation 
b) Bilateral aphakia as in children.. 
c) Corneal decompensation due to ACIOL. 
d) In combination with other procedures, such as pars plana lensectomy for the 
treatment of a dislocated crystalline lens, penetrating keratoplasty, or 
trabeculectomy. 
Secondary IOL implantation surgery should preferably be performed 4-6 
weeks after the initial surgery. 
3. SCLERAL FIXATION IOLs 
Gess9 first described scleral fixation of one haptic of a posterior chamber lens. 
In 1986, Malbran and colleagues10 described an open-sky technique for sutured PC 
IOLs, and in 1988, Cowden and Hu11 reported secondary PC lens implantation with 
scleral fixation of both haptics through scleral stab incisions. 
ADVANTAGES OF TRANSSCLERALLY SUTURED IOL 
FIXATION INCLUDE 
The elimination of corneal and angle trauma associated with anterior chamber 
lenses. 
1) Decreased risk of pupillary block and secondary glaucoma  
2) Little or no IOL contact with the iris, thereby decreasing the risk of iritis, 
pigment dispersion, and CME.12  
3) The sulcus location most closely approximates the normal anatomic position 
of the crystalline lens, and this method of PC IOL fixation minimizes the risk 
of pseudophakodonesis.13 
4) In addition, transsclerally sulcus–sutured posterior chamber IOLs 
theoretically can be used in any age group, including children,14-16 because 
the lenses are more likely than anterior chamber lenses to accommodate to 
the growing eye. 
 
 
DRAWBACKS TO TRANSSCLERALLY SUTURED IOL 
FIXATION INCLUDE 
1) Compared with AC IOL insertion and iris-sutured PC IOLs, the procedure is 
technically more difficult, requiring longer surgical time and a thorough 
anterior vitrectomy, both of which might increase the risk of intraoperative 
and postoperative complications. 
2)  It is difficult to precisely and symmetrically fixate both haptics within the 
ciliary sulcus.17-19 The anatomy of this space, which averages 11.0 ± 0.37 
mm in diameter20 and is located approximately 0.83 mm and 0.46 mm 
posterior to the surgical limbus in the vertical and horizontal meridians,21 
respectively, may be altered in long-standing aphakia.18  
In Pavlin's ultrasound biomicroscopy study of 34 transsclerally fixated PC 
IOLs, 13 IOLs were in the ciliary sulcus, 8 were posterior, and 13 were anterior.17 
Manabe also used the ultrasound biomicroscope to identify haptic placement 
and found only 32 of 86 haptics sutured at the sulcus; there were 29 at the ciliary 
processes, 25 posterior to the pars plicata, and 41 with vitreous incarceration.19  
Additionally, in a clinical study comparing complications of AC IOL versus 
transsclerally fixated PC IOL implantation, Bellucci showed that six of 32 PC IOLs 
were in the sulcus, 24 were in the pars plana, and 2 were in the iris root.18  
TECHNIQUES OF SUTURE PASSES 
Numerous variations for making the suture passes also have been explored. 
These include either an ab externo or ab interno approach, single or dual passes, and 
direct passage or capture with a 25- to 27-gauge hollow needle. Different IOL designs 
(i.e., with or without eyelets, one-piece or foldable) and suture needles (i.e., long or 
short, straight or curved) xist for different techniques. 
THE AB EXTERNO APPROACH 
The ab externo approach uses an outside to inside suture pass that allows 
more precise needle placement and reduces the duration of hypotony. 22 
TECHNIQUE FOR THE AB EXTERNO APPROACH 
1) The long, straight solid needle is passed through the sclera (usually under 
partial-thickness scleral flaps) approximately 0.75 mm posterior to the 
limbus. Inside the eye, the needle should exit at the ciliary sulcus. A second 
hollow needle is passed from the opposite side of the eye. A pair of sutures 
can be used if four-point fixation is desired. (Fig.1) 
2) Solid needle is “docked” inside the tip of the hollow needle, which has been 
passed through ciliary sulcus on the opposite side. After docking, the pair of 
needles are withdrawn together from the eye, with the solid needle inside 
the hollow needle. (Fig. 2) 
3) A hook is used to pull the suture out through a superior limbal wound so 
that it can be tied to the intraocular lens (IOL). (Fig. 3) 
4) Suture is cut, and each end is tied to a haptic of the IOL. After the IOL is 
placed into position, the scleral sutures must be anchored to the sclera. 
Either a “blind pass” in the sclera is made so that the suture is tied to itself, 
or the transscleral suture is tied to a second suture that has been tied to the 
sclera with a short partial-thickness pass within the bed of the scleral flap. 
(Fig. 4) 23  
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THE AB INTERNO APPROACH 
Ab interno techniques are performed by passing the suture needle from the 
inside to the outside of the eye, and have the advantage of being faster. 
TECHNIQUE FOR THE AB INTERNO APPROACH  
1) First the long needles are passed under the iris, aiming for the inferior ciliary 
sulcus. Two needle passes are made for each haptic if four-point fixation is 
desired. Needles exit under previously dissected scleral flaps. (Fig. 5) 
2) A second pair of short needle passes is made under the superior iris for the 
suture to be tied to the second haptic.(Fig.6)  
3) Girth hitch can be used to attach the polypropylene suture loop to the 
intraocular lens (IOL) haptic. This technique is more rapid than tying the 
suture to the haptic. Alternately, the suture can be attached to the IOL haptics 
before the transscleral needle passes, but the surgeon must avoid tangling the 
long sutures. (Fig. 7) 
4) After exiting the eye under the previously dissected scleral flaps, the sutures 
are tied securing the IOL into position. Appropriate suture tension is 
important to avoid lens decentration. The inset shows the cross-sectional 
view of the eye with the IOL correctly positioned in the ciliary sulcus.  
(Fig. 8) 24 
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SURGICAL TECHNIQUES OF SCLERAL FIXATION IOLs 
LEWIS TECHNIQUE 
1) A 7 mm limbal incision is made, anterior vitrectomy done and 2 limbal based 
conjunctival flaps are prepared at 2 and 8’o clock position. 
2) A 28-gauge hollow bore needle is passed through 2’o clock flap into 
posterior chamber and a straight needle with 10-0 polyprolene suture passed 
through 8’o clock flap is advanced into the hollow bore needle as far as 
possible (rail-road technique, Fig. 9) and the needle with the suture is 
withdrawn through 2’o clock flap. (Fig. 10) 
3) The straight needle is re-entered through 2’o clock flap 1.5 to 2 mm from the 
first suture’s exit and is exited through 8’o clock flap by rail-road technique 
again. (Fig. 11) 
4) Both the sutures in posterior chamber are retrieved with a hook through 7 
mm incision(Fig 12) , loops cut, separated and one suture from each pair is 
threaded into the islet of the haptic and threads of each pair tied together 
using 3-1-1 square knot. Each knot is rotated till it exits the eye. 
5) IOL is inserted (Fig. 13) and positioned in the ciliary sulcus and rotated by 
pulling on the sutures (Fig. 14). Sutures are cut, tied using 3-1-1 square knot, 
rotated again and knot buried in the flap (Fig. 15). 
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LANE’S TECHNIQUE 25 
1) After an anterior vitrectomy, a 7 mm scleral tunnel is made at the limbus and 
one end of a double-armed 10-0 polypropylene suture (Ethicon CTC-6L) is 
passed through the distal eyelet of the intraocular lens. The needle is walked 
under the iris, into the ciliary sulcus, and exits through the previously 
exposed scleral bed. (Fig. 16)26 
2) The second arm of this suture is passed in an identical manner so that it exits 
about 2 mm lateral to the first needle pass. (Fig. 17) 
3) The needle of a single-armed CTC-6L suture is passed through a paracentesis 
located about 150 degrees away from the center of the wound, through the 
pupil, under the iris, and out through the posterior scleral lip of the wound 
180 degrees away from the midpoint of the previous suture pass. (Fig. 18) 
4) The free end of this suture is retrieved from the pupillary space and brought 
through the wound with a microhook. It is then securely tied to the eyelet in 
the proximal haptic of the lens, ensuring that it is not entangled with any of 
the previously placed distal sutures. Care is taken to loop the double-armed 
suture symmetrically through the eyelets, thus minimizing torquing and 
tilting of the lens optic. (Fig. 19) 
5) All sutures are gently pulled to remove excessive slack, and gentle traction 
on the distal sutures helps to guide the lens as insertion forceps are used to 
carefully place the leading haptic in the sulcus. The trailing or proximal 
haptic then is tucked under the iris with the assistance of tying forceps and a 
hook. The sutures then are secured. For the leading haptic, this is 
accomplished by cutting off the needles and tying the suture ends together, 
cutting the suture close to the knot, and burying the knot by rotating it into 
the sclera. The proximal suture, which is still attached to its needle, is pulled 
up, and a partial-thickness scleral bite is taken in the posterior bed of the 
incision. The suture is tied to itself and then trimmed. This knot is covered by 
sclera and thus effectively buried when the wound is closed in a watertight 
fashion with 10-0 nylon. (Fig. 20) 
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FIGURE 20 
SUTURELESS INTRASCLERAL POSTERIOR CHAMBER 
INTRAOCULAR LENS FIXATION 27  
1) After a standard 3-port pars plana vitrectomy, a corneal incision is prepared 
for injector-assisted IOL implantation, 2 straight sclerotomies ab externo 
are prepared with a sharp 24-gauge cannula (Neopoint Luer #17) 1.5 to 2.0 
mm from the limbus, 180 degrees from each other. The position of the 
ciliary sulcus sclerotomy is controlled by visualization with an indirect 
viewing system (EIBOS [Mo¨ller- Wedel GmbH] or BIOM [Oculus]) and 
deep scleral indentation. (Fig. 21)  
2) The cannula is then used to create a limbus-parallel tunnel at about 50% 
scleral thickness, starting from the ciliary sulcus sclerotomies and ending 
with externalization of the cannula after 2.0 to 3.0 mm (Fig. 22) 
3) A standard 3-piece IOL with a haptic design the same diameter as the 
ciliary sulcus is implanted with an injector, and the tailing haptic is fixated 
in the corneal incision. The leading haptic is then grasped at the tip with an 
end-gripping 25-gauge forceps (Janach J383825), pulled through the 
sclerotomy, and left externalized. (Fig. 23)  
4) The forceps is introduced in the distal end of the limbus-parallel tunnel, 
grasps the externalized tip, and pulls the IOL haptic into the tunnel. After 
the trailing haptic is luxated intraocularly, the tip is grasped with the 25-
gauge end-gripping forceps and pulled through the second sclerotomy. The 
tailing haptic is then introduced into the limbus-parallel tunnel and the IOL 
is positioned and centered. The distal ends of the loops are insidethe tunnel 
to prevent a foreign-body sensation and reduce the risk for inflammation. 
(Fig. 24) 
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COMBINED SUTURE-IN-NEEDLE AND SCLERAL TUNNEL 
TECHNIQUE FOR SCLERAL FIXATION OF INTRAOCULAR 
LENS28 
This technique involves insertion of a 10-0 polypropylene suture into the 
barrel of a 27-gauge sharp needle and creation of scleral tunnels to bury the knots for 
transscleral IOL fixation. 
1) One end of a 10-0 polypropylene suture is inserted into a 27-gauge sharp 
needle (bottom left). The 27-gauge needle with the suture is passed through 
the roof of the scleral tunnel 1.0 mm posterior to the limbus. The loop of the 
suture, grabbed by a Sinskey hook, is pulled from the IOL implantation 
incision. (Fig. 25) 
2) The 27-gauge needle is retracted while the suture end remains inserted in 
the cannula; it is then passed through the roof of the scleral tunnel 1.0 to 2.0 
mm adjacent to the first pass of the needle. (Fig. 26,A) .The suture is 
grabbed by the Sinskey hook.(Fig. 26,B). The suture is pulled out of the 
IOL implantation incision to form a loop from the second fixation site. At 
this point, this is a free suture end and an extraocular loop from the 
implantation incision. (Fig. 26,C) 
3) The free end at the implantation incision is passed through the eyelet and a 
knot is tied and put through the loop.(Fig. 27,A). The suture end at the 
second scleral fixation site is slowly and gently pulled.(Fig. 27,B). The 
fixation suture is passed through the entire sclera at the ciliary sulcus and 
forms an extraocular loop via the implantation incision.(Fig. 27,C) 
4) Adouble loop is created at the tip of the extraocular loop by holding the 
suture with 1 forceps (lower) and pulling the tip of the loop back with 
another forceps (upper).(Fig. 28,A). The double-loop knot is set around the 
haptic and pulled to tighten. (Fig. 28, B) 
5) Each suture end is retrieved through the scleral tunnel opening by passing a 
Sinskey hook into the scleral tunnel and pulling the suture end through the 
external excision. The suture ends are tied, and the knot is buried under the 
roof of the scleral tunnel. (Fig. 29) 
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COMPLICATIONS OF SCLERAL FIXATION IOLs 
Despite its anatomic advantage, trans-sclerally fixated IOL is associated with 
complications primarily because of haptic contact with uveal tissue and the need for 
haptic fibrosis to ensure long-term stability. Even without suture fixation, sulcus 
placement of a lens implant carries the risks of lens decentration , pigment dispersion, 
uveitis, recurrent hemorrhage , ciliary body erosion,29-34 and, in one reported case, 
occlusion of the major arterial circle of the iris (located in the ciliary body), with 
devastating results.35 Transscleral fixation introduces additional risks caused by 
needle penetration of uveal and scleral tissue, abnormal positioning of the haptics, and 
external suture exposure; these risks include lens tilt and decentration , lens 
subluxation, episcleritis, corneal decompensation, hypotony, PAS formation, 
secondary glaucoma, hyphema, vitreous hemorrhage, suprachoroidal hemorrhage, 
choroidal effusion, CME, RD, external suture erosion, and endophthalmitis. 
 
 
SUTURE EROSION 
 Anand and Bowman36 first described using scleral flaps to cover and protect 
the suture knots. However, Solomon37 found a 73% rate of suture erosion through 
scleral flaps, suggesting that this approach delays but does not prevent this 
complication. Friedberg38 created scleral grooves in which the knots were secured 
and then protected. Later, Bucci and coworkers39 showed that covering the knot with 
corneal tissue prevents erosion. Lewis40,41 subsequently reported methods for burying 
the suture knots in the sclera to avoid erosion through sclera and conjunctiva. 
If suture erosion does occur, this problem can be treated in several ways, including 
cutting the free ends flush on the knot, cauterizing the knot, revising the scleral flap, 
or using a scleral patch graft.54 A number of cases have been reported in which the 
sutures were removed, either to treat suture erosion or inadvertently. As a general 
rule, this is not recommended as lens decentration or dislocation can result, because 
there may be little or no fibrosis of the lens haptic to uveal tissue.55 
POST-OPERATIVE GLAUCOMA, CORNEAL EDEMA 
Lindstrom and Harris42 found the incidence of various complications to be 
as great as 19.8% for CME, 10.8% for hyphema, 8% for secondary glaucoma, 5.4% 
for corneal edema, 3.3% for uveitis, and 1.6% for retinal detachment. In their personal 
experience with 153 cases, the incidences of the same sequelae were 4.6%, 0.7%, 
3.9%, 2%, 2.6%, and 1.3%, respectively, with 81.6% of patients attaining visual 
acuity of 20/40 or better and 8.5% losing two or more lines of BSCVA. Depending on 
the study, as many as 94% of eyes achieved better than 20/40 vision, and the loss of 
more than two lines of BSCVA ranged from 3% to 10%.42,43,44-46 However, these 
reports antedated the availability of multiflex-style anterior chamber IOLs and sutured 
posterior chamber IOLs.  
CYSTOID MACULAR EDEMA AND RETINAL DETACHMENT 
The roles of vitreous loss and vitrectomy and their relationships to the 
development of CME and RD during the implantation of secondary AC IOLs is 
controversial. Cozean46 suggested that there is a correlation between CME and 
disruption of the vitreous. Shammas and Milkie47 also noted this relationship and 
stated that the incidence of CME increases if the secondary IOL implantation is 
performed within 1 year of intracapsular cataract extraction, the preoperative 
fluorescein angiogram is positive for CME, or there is vitreous loss. Kraff and 
colleagues48 reported that vitrectomy may increase the risk of RD. Wong and 
colleagues49 also suggested that vitrectomy might increase the chance of RD (their 
rate was 4%), but might lower the risk of CME, which they found to be 3%. Not 
surprisingly, this study also found a higher incidence of these problems in eyes with 
closed-loop anterior chamber as opposed to sulcus-placed posterior chamber lenses. 
Conversely, Lyle and Jin50 reported similar incidences of CME (6%) when 
comparing eyes that received an AC IOL or PC IOL (68% had scleral suture fixation), 
but the rate of RD was higher in the latter group (0.8% for AC IOL versus 3.5% for 
PC IOL). Posterior vitreous detachment and vitreous liquefaction occurs in most 
aphakic eyes within 1 year postoperatively;51 this may suggest an explanation for the 
decreased RD rate when secondary IOL insertion is performed after 1 year.52,53 
 
 
Glaucoma and RD have been described in as many as 19% and 5.4% of eyes 
receiving sutured PC IOLs, respectively.56 The reported incidence of new CME has 
ranged from 0%54 to 18% in patients receiving a transsclerally sulcus-sutured PC 
IOL.41  
HYPHEMA AND VITREOUS HAEMORRHAGE 
Price and Wellemeyer found hyphema and/or vitreous hemorrhage in 13% of 
eyes, although Bleckmann and Kaczmarek57 reported hyphema in 16.7% and 
vitreous hemorrhage in 25% of patients in their series. Other studies, however, state 
much lower incidences of intraocular bleeding, such as Helal's group,58 which had a 
4.9% rate of hyphema. 
LENS TILT AND DECENTRATION 
Lens tilt and decentration are potential complications that may occur in as 
many as 10% of cases with transsclerally sulcus–sutured PC IOLs54. Lens tilt occurs 
because of the torque created by asymmetric suture placement on the IOL. 
Teichmann59 studied the combinations of suture configurations and found that only 
four were torque free. He recommended looping the sutures symmetrically through 
the opposing eyelets. Theoretically, tilt also can be eliminated with radial suture 
placement, but this is anatomically undesirable, because one of the sutures will exit 
through the ciliary body. In Sharpe's study of children,60 an IOL tilt of 15 degrees in 
one case produced 6.5 D of cylinder. A decentered sutured PC IOL may result from a 
number of factors. These include asymmetric attachment of the sutures to the haptics; 
failure to place the needles through the sclera 180 degrees apart; and suture loosening, 
breakage, or slippage on the haptics. Therefore, to prevent lens malposition, it is 
important to use an IOL with eyelets on the haptics, symmetrically secure the sutures 
to the eyelet, and place the needle passes an equal distance from the limbus and 
exactly 180 degrees apart. Fortunately, small degrees of lens tilt (less than 10 degrees) 
and decentration (less than 2 mm) are asymptomatic and clinically insignificant.61,57 
To summarise, the complications of scleral fixation IOLs are : 
Intra-operative complications 
Intraoperative AC hemorrhage 
Early complications (within 1 month) 
1. Fibrin  
2. Increase IOP>30 mm Hg  
3. Corneal oedema 
4. Hyphaema 
5. Vitreous haemorrhage 
Late complications (after 1 month) 
1. Glaucoma 
2. Pupil deformation  
3. Persistent uveitis (AC cells>1+) 
4. Cystoid macular oedema.  
5. Vitreous prolapse into anterior chamber 
6. IOL decentration 
7. IOL surface debris 
8. Pseudophakic bullous keratopathy 
9. Suture erosion 
AIM OF THE STUDY 
The aim of the study is to analyze--- 
1) The long-term functional and visual outcome  
2) To analyze the long term complication profile of combined anterior 
vitrectomy and scleral fixated posterior chamber intraocular lens (SFIOL) 
implantation without adequate capsular support. 
MATERIALS AND METHODS 
This prospective clinical study was done to evaluate the long term functional 
and visual outcome and complication profile following implantation of scleral fixated 
posterior chamber intraocular lens (SFIOL) without capsular support. 
MATERIALS 
This study was done at Coimbatore Medical College Hospital, Coimbatore. 
The study includes 30 eyes of 25 aphakic patients and 5 primary SFIOL with a follow 
up of 1 year were selected, from May 2008 to December 2009.  
18 other eyes with partial capsular remnants, a secondary PCIOL was 
implanted and their visual prognosis was assessed during the same period. 
Regarding history the following data were collected: Name, age, sex, duration 
of aphakia, history of trauma, history of past ocular surgery, presence of diplopia. 
History of certain systemic diseases like Diabetes, Hypertension, Cardiac disease, 
Bronchial asthma. Random, Fasting and Postprandial blood sugar was taken as a 
routine for all patients. Blood pressure was taken in sitting position preoperatively. 
These patients were taken up for surgery after control of these systemic problems. 
METHODS 
Routine examination of anterior segment was done with  slit lamp. Presence of 
aphakia and status of posterior capsule was noted. Presence of vitreous strands in the 
pupillary area and in the anterior chamber was also noted. Pupillary peeking ,posterior 
synechiae and the presence of peripheral iridectomy was assessed. 
PREOPERATIVE VISUAL ACUITY ASSESSMENT 
Baseline visual acuity without correction and with correction was obtained in 
all individuals with Snellen’s distance visual acuity chart and near acuity chart. 
INTRAOCULAR PRESSURE 
Goldmann applation tonometer was used to record IOP for all cases 
preoperatively. Non contact Pulsair tonometer was used in all cases to record IOP 
postoperatively for a period of 1 month. Thereafter Goldmann applanation tonometer 
was used for recording the IOP. All IOP measurements were done by a single 
observer. 
FUNDUS 
Fundus oculi was examined by direct ophthalmoscopy. Also indirect 
ophthalmoscopy with +20 D lens was done in all cases to evaluate the periphery of 
the retina. 
IOL POWER CALCULATION 
Keratometry was done with Bausch and Lomb keratometer. K1 and K2 
readings were taken. Axial length of the eye was done with the help of ‘A’ scan. IOL 
power was calculated with SRK formula using 118.2 as A constant for scleral fixation 
IOL. 
INCLUSION CRITERIA 
1) Patients with unilateral aphakia / unilateral lens subluxation or dislocation. 
2) Interval between the primary procedure and the secondary IOL procedure 
minimum 6 weeks. 
3) BCVA better than or equal to 6/24 by Snellen’s visual acuity chart 
4) Normal fundus as seen by direct ophthalmoscopy and +20D   indirect 
ophthalmoscopy. 
EXCLUSION CRITERIA 
1) Patients with bilateral aphakia. 
2) BCVA worse than 6/24 by Snellen’s visual acuity chart. 
3) Any fundus abnormality affecting visual function like macular 
degeneration,chorioretinal atrophy etc. 
4) Presence of other disorders contributing to decrease in visual acuity. 
5) One eyed patient. 
PREOPERATIVE PREPARATION 
After taking a detailed medical history and a thorough checkup including B.P., 
blood sugar, cardiovascular assessment respiratory system assessment, G.I assessment 
and CNS assessment, eyelash cutting is done. 
MYDRIASIS 
Preoperatively pupils were dilated with 0.5% tropicamide, 10% phenylephrine 
& flurbiprofen. All these drops were instilled every 15 minutes one hour before 
surgery. Pupillary distortion and presence of peripheral iridectomy with its patency 
were noted. 
 
 
AKINESIA AND ANAESTHESIA 
These were achieved by peribulbar injection of 2.5 ml to 5 ml of 2% xylocaine 
with 5 I.U./ml hyaluronidase and 1:200,000 adrenaline given with a disposable 23G 
needle. Peribulbar injection was given at the junction of lateral 1/3rd and medial 2/3rd 
of the lower lid. Adrenaline was avoided in patients with cardiovascular problems. 
LOWERING OF IOP 
Ocular hypotony was achieved by ocular compression using steady digital 
pressure on globe for 20 seconds period separated by 10 seconds interval . 
CLEANING OF SKIN AND CONJUNCTIVA 
Preparation included use of 5% povidone iodine to clean the surrounding skin. 
Skin area that was cleaned extended from midline to beyond lateral canthus and from 
above the eyebrow to well down onto the cheek. 5% iodine solution was applied into 
conjunctival cul de sac with subsequent saline wash to cleanse the conjunctiva. 
DRAPING THE SURGICAL FIELD 
The eye and the surrounding sterile periocular region was draped with a sterile 
cloth with an 3cm x 3cm round opening for the eye. 
SURGICAL PROCEDURE 
Step 1: Superior rectus bridle suture and Conjunctival peritomy 
Superior rectus bridle suture is applied and a Conjunctival peritomy is done 
for 7 mm at superior limbus and 2 small peritomies are done each at 2 o’clock and 8 
o’clock respectively. 
Step 2: Hemostasis 
Bipolar wet field cautery is used for hemostasis 
Step 3: Scleral flaps 
Horizontal 2/3rd thickness outer scleral flap of 6.5 mm length is made 1mm 
from the limbus. Two 2 mm 2/3 rd thickness scleral flaps are made 2 mm from the 
limbus at 2 o’clock and 8 o’clock respectively. 
Step 4: AC entry  
AC entry is made with a 2.8 mm diameter keratome. The keratome entry is 
extended upto the width of the external scleral flap i.e. 6.5 mm. 
Step 6: Automated 23 G Anterior vitrectomy  
A thorough Automated 23 G Anterior vitrectomy is done. Any peripheral 
cortical remnants are cleared with the vitrectomy. 
Step 7: Railroad technique 
A 26-gauge needle is passed into the vitreous cavity through the upper end of 
the 2 o'clock groove and directed into the pupillary space, just posterior to the iris. In 
the upper end of the 8 o'clock groove, 180° away, a straight needle (Ethicon STC-6 
Plus) attached to a 10-0 Polypropylene suture is similarly placed and directed into the 
lumen of the 26-gauge needle, where it is lodged. The 26-gauge needle is withdrawn, 
pulling the straight needle and the attached 10-0 Polypropylene suture with it. A 
Polypropylene suture now spans the posterior chamber, exiting near the upper end of 
each groove. This technique is known as the Railroad technique. 
Another indigenious technique was also used in about 15 cases where the end 
of a 10-0 polypropylene suture was threaded into the bore of the 26G needle and 
passes from the two scleral flaps into the posterior chamber .The suture was the taken 
out from the main scleral tunnel superiorly by Mcferson’s forceps.Thus the two ends 
of sutures were  tied to the routine PCIOL,s haptics and the IOL was implanted in the 
posterior chamber after centering and then sutured. 
Step 8: Suture retrieval and tying to the haptics 
The posterior chamber suture is retrieved with a hook, cut, and tied to the 
haptics of the SFIOL. Care is taken to ensure that the 2 o’clock suture is matched with 
the superior eyelet of the haptic and that the inferior haptic eyelet likewise related to 8 
o’clock suture exiting the inferior aspect of the groove. The knots are tied to the 
haptic in a 3:3:2:1 pattern. 
Step 9: IOL insertion, centering and burying knots in the groove. 
The SFIOL is inserted into the anterior chamber and the lens was placed in the 
eye posterior to the iris and centered. The 2 o’clock and 8 o’clock sutures were 
sutured and buried in the scleral bed in the groove. 
Step 10: Wound closure  
A spatulated needle on 10-0 nylon suture is used to close the main superior 
scleral flap if it was not adequately reformed with air or saline with interrupted 
sutures. Anterior chamber is reformed with air. 
 
Step 11: Conjunctival approximation and sub-conjunctival injection 
Conjunctival approximation is done and 0.5 ml of subconjunctival injection 
containing 0.5 ml gentamicin and 0.5 ml dexamethasone is given. 
POSTOPERATIVE MANAGEMENT AND EVALUATION 
Eye was patched with the application of protective shield. Topical ofloxacin 
and dexamethasone eye drops were given for a period of 6 weeks.If postoperative 
inflammation was more or were anticipated to be more then 1% prednisolone with 
ofloxacin eye drops were given. Main scleral flap sutures were removed after 
postoperative 2 months. 
Postoperative day 1 
 Patient is examined for 
1) Wound approximation. 
2) Corneal status. 
3) Anterior chamber depth and reaction. 
4) IOL centration. 
5) IOP by non-contact pulsair tonometry. 
Postoperative day 2 
Above parameters with fundus examination with direct and indirect 
ophthalmoscopy. 
 
Postoperative 1 month/ 6 months/1 year 
 Patient was examined for 
1) Visual acuity with Snellens distance visual acuity chart and Jaeger’s near 
chart. 
2) Corneal status. 
3) Anterior chamber depth and reaction. 
4) IOL centration and IOL surface examination. 
5) IOP by Applanation tonometry. 
6) Fundus evaluation by +20D indirect ophthalmoscopy and direct 
ophthalmoscopy. 
7) Any associated complication/s. 
TABLE 1 
DEMOGRAPHICS 
 
AGE GROUP NO. OF CASES % 
41-50 2 7 
51-60 10 33 
61-70 14 47 
71-80 4 13 
81-90 0 0 
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In our study  47%  of  our patients belonged to the age group 61-70 years 
TABLE 2 
 
GENDER NO. OF CASES % 
MALE 10 33 
FEMALE 20 67 
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TABLE 3 
SYSTEMIC DISEASE PROFILE 
 
SYSTEMIC DISEASE NO. OF CASES % 
DIABETES 4 13 
HYPERTENSION 2 7 
CONGESTIVE CARDIAC 
FAILURE 
0 0 
BRONCHIAL ASTHMA 1 3 
TRAUMA 2 7 
NONE 21 70 
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70% of the cases in our study had no active or chronic systemic illness.
TABLE 4 
LATERALITY 
 
LATERALITY NO. OF CASES % 
RIGHT EYE 19 63 
LEFT EYE 11 37 
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37%
RIGHT EYE
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TABLE 5 
PROCEDURE 
 
PROCEDURE NO. OF CASES % 
SCLERAL FIXATION -
SECONDARY 
25 83 
PRIMARY    SCLERAL 
FIXATION 
5 17 
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83% of the cases were aphakic. 5 cases (17%), a primary scleral fixation was done. 
  
TABLE 6 
PREOPERATIVE BCVA 
 
VISUAL ACUITY NO. OF CASES % 
6/6 1 3 
6/9 8 28 
6/12 10 33 
6/18 4 13 
6/24 3 10 
6/60 and less 4 13 
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64% of cases in our series had a preoperative BCVA of 6/12 and above.  
TABLE 7 
PREOPERATIVE IOP 
 
IOP NO. OF CASES % 
< 10 MM HG. 0 0 
10-20 MM HG. 28 93 
20-30 MM HG. 2 7 
> 30 MM HG. 0 0 
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93% of our patients had  an  normal  IOP (20-30mm Hg). 
TABLE 8 
BCVA 24 HOURS POSTOPERATIVELY 
 
VISUAL ACUITY NO. OF CASES % 
6/6 0 0 
6/9 3 10 
6/12 11 37 
6/18 9 30 
6/24 4 13 
6/36 0 0 
6/60 and less 3 10 
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BCVA of 6/12 was observed in 11 cases (37%) in the first postoperative day. 
TABLE 9 
COMPLICATION PROFILE 24 HOURS POSTOPERATIVELY 
 
COMPLICATION NO. OF CASES % 
WOUND LEAK 0 0 
SK 4 13 
CORNEAL EDEMA 3 10 
HYPHAEMA 1 3 
AC SHALLOW 0 0 
AC FLARE & CELLS                10 33 
PUPILLARY CAPTURE 0 0 
IOL DECENTRATION 1 3 
↑ IOP > 30 MM HG 2 7 
VITREOUS HAEMORRHAGE 2 7 
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 10 cases (33%)  had mild  flare  and cells in the first Postoperative Period.
TABLE 10  
BCVA 1 MONTH POSTOPERATIVELY 
 
VISUAL ACUITY NO. OF CASES % 
6/6 1 3 
6/9 3 10 
6/12 14 47 
6/18 6 20 
6/24 3 10 
6/36 0 0 
6/60 and less 3 10 
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47% of the cases had a BCVA of 6/12 at one month. 
TABLE 11 
COMPLICATION PROFILE 1 MONTH POSTOPERATIVELY 
 
COMPLICATION NO. OF CASES % 
FIBRIN 0 0 
CORNEAL EDEMA 3 10 
HYPHAEMA 0 0 
ANTERIOR UVEITIS 5 17 
PUPILLARY CAPTURE 0 0 
IOL DECENTRATION 1 3 
↑ IOP > 30 MM HG 2 7 
VITREOUS HAEMORRHAGE 2 7 
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5 cases (17%) had anterior uveitis. 2 cases had vitreous haemorrhage. 
TABLE 12 
BCVA 6 MONTHS POSTOPERATIVELY 
 
VISUAL ACUITY NO. OF CASES % 
6/6 1 3 
6/9 7 23 
6/12 13 44 
6/18 3 10 
6/24 3 10 
6/36 1 3 
6/60 and less 2 7 
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 70% (21 cases) had a BCVA of 6/12 and above at 6 months postoperative. 
TABLE 13 
COMPLICATION PROFILE 6 MONTHS POSTOPERATIVELY 
 
COMPLICATION NO. OF CASES % 
GLAUCOMA 0 0 
PUPIL DEFORMATION 0 0 
PERSISTENT UVEITIS 2 7 
CYSTOID MACULAR EDEMA 2 7 
VITREOUS PROLAPSE IN ANTERIOR 
CHAMBER 
1 3 
IOL DECENTRATION 1 3 
SUTURE EROSION 0 0 
IOL SURFACE  DEBRIS    1 3 
 
0 0
2 2
1 1
0
1
0
0.5
1
1.5
2
2.5
GL
AU
CO
MA
PU
PIL
 D
EF
OR
MA
TIO
N
PE
RS
IST
EN
T U
VE
ITI
S
CY
ST
OI
D 
MA
CU
LA
R 
ED
EM
A
VIT
RE
OU
S P
RO
LA
PS
E I
N 
AN
TE
RI
OR
 C
HA
MB
ER
IO
L D
EC
EN
TR
AT
IO
N
SU
TU
RE
 ER
OS
IO
N
IO
L S
UR
FA
CE
  D
EB
RI
S  
   COMPLICATION
N
O
. O
F 
C
A
SE
S
TABLE 14 
BCVA 1 YEAR POSTOPERATIVELY 
 
VISUAL ACUITY NO. OF CASES % 
6/6 1 3 
6/9 7 23 
6/12 13 44 
6/18 4 13 
6/24 2 7 
6/36 1 3 
6/60 and less 2 7 
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70% cases in our study had a BCVA of 6/12 and above at 1 year
TABLE 15 
COMPLICATION PROFILE 1 YEAR POSTOPERATIVELY 
 
COMPLICATION NO. OF CASES % 
GLAUCOMA 0 0 
PUPIL DEFORMATION 0 0 
PERSISTENT UVEITIS 2 7 
CYSTOID MACULAR EDEMA 2 7 
VITREOUS PROLAPSE IN ANTERIOR 
CHAMBER 
1 3 
IOL DECENTRATION 1 3 
IOL SURFACE DEBRIS 1 3 
SUTURE EROSION 0 0 
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In our study persistant uveitis was seen in 7% of cases & CMO in 7% of cases 
TABLE 16 
CHANGES IN VISUAL ACUITY AT THE END OF 1 YEAR 
 
VISUAL ACUITY NO. OF CASES % 
1 line deterioration from 
baseline 
6 20 
More than 1 line deterioration 
from baseline 
4 13 
Improvement from baseline  6 20 
No change in visual acuity 14 47 
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47% cases in our study had no change in visual acuity from preoperative BCVA.20% 
had one line deterioration. 
RAIL ROAD TECHNIQUE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LONGTERM FUNCTIONAL OUTCOME 
Excellent long term( 1 year) visual outcomes were achieved in  our study of 
scleral fixation IOL’s .The preoperative best corrected visual  acuity(BCVA)  was 
used as a control to assess the final visual outcome .More than 86% of the patients 
achieved a postoperative BCVA within one line of the preoperative best corrected 
visual acuity. 
Loss of more than one line from baseline was attributed to cystoid macular 
edema in two eyes, persistent uveitis and IOL surface debris was the reason in two 
other eyes. 
One eye had a slightly decentered IOL, but the long term visual outcome was 
not affected . In our series no suture erosion was encountered, as we had buried the 
knot in the inferior and superior groove. A adequate anterior vitrectomy and 
placement of the IOL as close to the ciliary sulcus were the reason for the good long 
term visual outcome.    
In the other 18 Aphakic eye which had partial capsular remnants ,a PCIOL 
was implanted over it.The capsular remnants and the condensed anterior hyloid phase 
provided adequate support for the IOL to be in place.The postoperative complications 
were mild ranging from mild iritis to mild corneal edema in few cases which resolved 
within the first postoperative week.The IOL in all cases were well centered and visual 
acuity were equal or better than the preoperative BCVA. 
Thus placing a secondary PCIOL in an eye with doubtful capsular support 
with a condensed anterior vitreous phase is a good if not a better alternative for 
SFIOL. 
OBSERVATIONS 
A prospective study of 30 cases was done from May 2008 to December 2009 
with patients undergoing Scleral fixation IOL. Out of these 10 were males and 20 
females accounting for 33% and 67% respectively. Mean age was found to be 65 
years.. Types of patients considered include unilateral aphakics with a minimum 
interval between primary and secondary procedure of 6 weeks and patients who were 
implanted SFIOL as a primary procedure. There 25 aphakic patients who underwent 
secondary SFIOL accounting for 83% of the total and 5 patients who underwent a 
primary SFIOL accounting for 17%. 18 aphakics with partial capsular remnants 
underwent secondary PCIOL during the same period. 
The mean interval between the initial cataract surgery and secondary SFIOL 
implantation was 14.25 weeks (range 6 weeks to 72 weeks). 
All 30 cases underwent automated 23 G anterior vitrectomy and scleral 
fixation IOL. There were intraoperative complications like vitreous hemorrhage in 2 
cases, in 3 cases the suture broke while tying the knot and the procedure was redone 
again from the beginning and surgery was uneventful rest of the cases. 
Immediate postoperative complications – AC flare and cells were seen in 10 
cases (33%),striate keratopathy was seen in 4 cases (13%), corneal edema was seen in 
4 cases (13%) . 
Late postoperative complications – persistent uveitis was seen in 2 case (7 %), 
cystoid macular edema was seen in 2 case (7%),vitreous prolapse in anterior chamber 
was seen in 1 case (3%),IOL decentration was seen in 1 case (3%). 
DISCUSSION 
In our case series study of  30 cases, 25 cases were taken up for secondary 
suturing of scleral fixation IOL. 
Five cases, of which 2 were traumatic subluxted cataractous lens  and  the rest 
(3 cases) ,had a large capsular tear during routine small incision cataract surgery ,were 
taken up for primary suturing of scleral fixation IOL. The mean follow up period was 
12 months.the best corrected visual acuity of 6/12 and above was seen in 21 cases 
(70%). 
Two cases of traumatic subluxated lens who underwent primary fixation had a 
BCVA at 1 year of 6/60 and 6/36 respectively. They had mild persistant uveitis. The 
visual acuity was better than the preoperative best corrected vision. 
IOL decentration was observed in one case,but did not affect the visual acuity 
significantly  as it was minimal. 
Vitreous prolapse was observed in one case. 
Cystoid macular edema was seen in one case who had a vitreous haemorrhage 
in the immediate postoperative period which cleared after 6 months.The BCVA was 
6/60. 
COMPARISON WITH PREVIOUS STUDIES 
1. Chang and Lee62 did a case series study of 18 cases of uncomplicated 
secondary suturing of scleral fixation IOL.  Their study showed a Visual 
outcome of 20/40 or better in 14 (77.8%) and of 20/200 or worse in 3 (16.7%) 
of patients. Corneal edema was seen in 2 (11.1%) and Glaucoma escalation in 
1 (5.6%). None of the patients had cystoid macular edema, retinal detachment 
and  endophthalmitis. 
In Our study 70% had BCVA of 6/12 and above .None had Retinal 
detachment, or endophthalmitis.CME was observed in 2 cases. 
2. Menezo et al63 did a case series study of 13 cases of uncomplicated secondary 
suturing of scleral fixation IOL. Their study showed a visual outcome of 
20/40 or better  in 10 (76.9%) and of 20/200 or worsein 2 (15.3%) of 
patients. Corneal edema was seen in 1 (7.6%) and  Glaucoma escalation in 4 
(30.7%). Cystoid macular edema was seen in 1 (7.6%). Lens tilt or dislocation 
was seen in 2 (15.3%) patients. Endophthalmitis was seen in 1 (7.6%). 
No lens tilt or endohthalmitis was seen in our series.Corneal edema was seen 
in the immediate postoperative period and which resolved by two months. 
3. Helal et al64 did a case series study of 41 cases of uncomplicated secondary 
suturing of scleral fixation IOL. Their study showed a visual outcome of 20/40 
or better in 25 (61.0%) and of 20/200 or worse in none. Glaucoma escalation 
was seen in 1 (2.4%) and Lens tilt or dislocation in 1 (2.4%). Retinal 
detachment was seen 1 (2.4%). 
4. McCluskey and Harrisberg65 did a case series study of 12 cases of 
uncomplicated secondary suturing of scleral fixation IOL. Their study showed 
a visual outcome of 20/40 or better in 7 (58.3%) and of 20/200 or worse in 2 
(16.7%). Suture erosion was seen in 1 (8.3%) patient. 
No suture erosion was observed in our study,as we had buried the suture knot 
under the scleral groove . 
5. The large series of secondary scleral-sutured PC IOLs by Lyle and Jin66 , 
more than 90% of eyes achieved a BCVA of 20/40 or better. If risk factors 
such as glaucomatous optic nerve damage or maculopathy were present, the 
percentage of eyes achieving a BCVA of 20/40 or better was reduced to 66%. 
The incidence of retinal detachment was 3.5%; lens tilt or dislocation, 2.6%; 
and endophthalmitis, 0.9%.  
In our series cases with risk factors were not included. All cases had 
undergone an anterior vitrectomy, thus eliminating the traction component and 
the lens were laced as close to the ciliary sulcus as possible.This could explain 
the abscence of retinal detachment in our study.     
6.  Belluci et al67 achieved similar visual outcomes, with a retinal detachment 
rate of 6%, lens tilt or dislocation of 12%, and no cases of endophthalmitis. 
   
SUMMARY AND CONCLUSION 
A prospective study was conducted at Coimbatore Medical College Hospital, 
Coimbatore from May 2008 to December 2009 which included 30 eyes of 25 aphakic 
patients, 5cases of primary scleral fixation lenses and with a follow up of 1 year were 
evaluated for long-term functional and visual outcome . The complication profile for 
combined anterior vitrectomy and scleral fixated posterior chamber intraocular lens 
(SFIOL) implantation without adequate capsular support were studied. 
Results concluded that scleral fixation procedure was a safe procedure with a 
success rate of  93% . Most preoperative complications were minor: suture break 
while tying the knot after centering the IOL was observed in 3 cases,and the 
procedure was redone again. Post operative complications encountered were mild 
iritis in 1 cases , one eyes had a  decenteration of IOL , 4 eye had a striate keratopathy 
which cleared in the second postoperative period.  
Two eyes had  intraoperative vitreous haemorrhage, which cleared after 
3months postoperarative, two patients ,who had a traumatic subluxation and SFIOL 
implanted had chronic anterior uveitis which did not improve beyond 6/60 and 6/36 at 
6 months follow up.Visual acuity was assessed at second day,at one month and three 
month .  Scleral fixation of PCIOLs can be visually rewarding in most cases.Most 
cases improved from one line to three lines in snellens visual acuity chart.  The 
postoperative astigmatism ranged from 1.5D to as high as 3.5D.  
Precise determination of small differences in visual outcome or complication 
rates will require a large prospective, randomized clinical trial.  
CONCLUSION 
In this study combined anterior vitrectomy and scleral fixated posterior 
chamber intraocular lens (SFIOL) implantation was found to have the following 
outcome: 
1. Combined anterior vitrectomy and scleral-fixated sutured PC IOL 
implantation is an effective and safe procedure to correct aphakia in eyes 
without capsular support.. 
2. The most dreaded complication of retinal detachment, suture lysis and 
infection was not encountered. 
3. Discomfort and anisekonia from wearing aphakic spectacles, and the 
devastating complications from ACIOL implantation (such as bullous 
keratopathy, glaucoma, CME etc…) are avoided with SFIOL implantation as 
there is anatomic placement of the IOL in the posterior segment. 
4. If there is peripheral capsular support and an condensed anterior hyaloid 
phase a secondary PCIOL implantation can be tried .In a skilled surgeon it is 
a safer alternative than an SFIOL.  
BIBLIOGRAPHY 
1. Steinert RF. Surgical alternatives in monocular aphakia. Focal Points 1990: 
Clinical Modules for Ophthalmologists, vol. 8. American Academy of 
Ophthalmology, 1990, p 1. 
2. Waring GO III. The 50-year epidemic of pseudophakic corneal edema 
[editorial]. Arch Ophthalmol 1989;107:657–9. 
3.  Apple DJ, Mamalis N, Loftfield K, et al. Complications of intraocular 
lenses. A historical and histopathological review. Surv Ophthalmol 
1984;29:1–54. 
4.  Miyake K, Asakura M, Kobayashi H. Effect of intraocular lens fixation on 
the blood-aqueous barrier. Am J Ophthalmol 1984;98:451–5.  
5. Apple D, Mamalis N, Loftfield K, et al. Complications of intraocular lenses: 
a historical and histopathological review. Surv Ophthalmol 1984;29:l–54.  
6. Stark WJ, Gottsch JD, Goodman DP, et al. Posterior chamber intraocular lens 
implantation .in the absence of capsular support. Arch Ophthalmol 
1989;107:1078–83.  
7. Holladay JT. Evaluating the intraocular lens optic. Surv Ophthalmol 
1986;30:385–90.  
8. Wagoner MD, Cox TA, Ariyasu RG, Jacobs DS, Karp CL. Intraocular lens 
implantation in the absence of capsular support: a report by the American 
Academy of Ophthalmology. Ophthalmology 2003;110:840–859.  
9. Gess LA: Scleral fixation for intraocular lenses. Am Intraocular Implant Soc 
J 9:453, 1983 
10.  Malbran ES, Malbran EJ, Negir I: Lens guide suture for transport and 
fixation in secondary IOL implantation after intracapsular extraction. In 
Ophthalmol 9:161, 1986 
11.  Cowden JW, Hu BV: A new surgical technique for posterior chamber lens 
fixation during penetrating keratoplasty in the absence of capsular or zonular 
support. Cornea 7:231, 1988 
12. Apple DJ, Mamalis N, Lotfield K, et al: Complications of intraocular lenses: 
A historical and histopathological review. Surv Ophthalmol 29:1, 1984 
13. Binkhorst CD: Corneal and retinal complications after cataract extraction: 
The mechanical aspect of endophthalmodonesis. Ophthalmology 87:609, 
1980 
14. Sharpe MR, Biglan AW, Gerontis CC: Scleral fixation of posterior chamber 
intraocular lenses in children. Ophthalmic Surg Lasers 27:337, 1996 
15. Buckley EG: Scleral fixated (sutured) posterior chamber intraocular lens 
implantation in children. J AAPOS 3:289, 1999 
16.  Mittelviefhaus H, Mittelviefhaus K, Gerling J: Transscleral suture fixation of 
posterior chamber intraocular lenses in children under 3 years. Graefes Arch 
Clin Exp Ophthalmol 238:143, 2000 
17. Pavlin CJ, Rootman D, Arshinoff S, et al: Determination of haptic position of 
transsclerally fixated posterior chamber intraocular lenses by ultrasound 
biomicroscopy. J Cataract Refract Surg 19:573, 1993 
18.  Bellucci R, Marchini G, Morselli S, et al: Scleral fixation re-examined by 
ultrasound biomicroscopy. Eur J Implant Refract Surg 7:326, 1995 
19. Manabe S, Oh H, Amino K, et al: Ultrasound biomicroscopic analysis of 
posterior chamber intraocular lenses with transscleral sulcus suture. 
Ophthalmology 107:2172, 2000 
20. Campbell D, Davis R, Ferguson J: Ciliary sulcus anatomical dimensions. 
Invest Ophthalmol Vis Sci 29(suppl):34, 29 (abstract) 
21. Duffey RJ, Holland EJ, Agapitos PJ, Lindstrom RL: Anatomic study of 
transsclerally sutured intraocular lens implantation. Am J Ophthalmol 
108:300, 1989 
22. Steinert RF: Cataract Surgery: Techniques, Complications and Management, 
2nd ed. Philadelphia: Saunders, 2004:433 
23. Steinert RF, Arkin MS:. Secondary intraocular lenses. In: Steinert RF, ed. 
Cataract Surgery: Techniques, Complications, and Management,. 2nd ed. 
Philadelphia: Saunders, 2004:434 
24. Steinert RF, Arkin MS:. Secondary intraocular lenses. In: Steinert RF, ed. 
Cataract Surgery: Techniques, Complications, and Management,. 2nd ed. 
Philadelphia: :Saunders, 2004:433 
25. Lane SS, Lubniewski AJ, Holland EJ: Transsclerally sutured posterior 
chamber lenses: Improved lens designs and techniques to maximize lens 
stability and minimize suture erosion. Semin Ophthalmol 7:245, 1992 
26. Duffey RJ, Holland EJ, Agapitos PJ, Lindstrom RL: Anatomic study of 
transsclerally sutured intraocular lens implantation. Am J Ophthalmol 
108:300, 1989 
27. Scharioth G.B. Gabor, Mitrofanis M. Pavlidis : Sutureless intrascleral 
posterior chamber intraocular lens fixation. J Cataract Refract Surg 2007; 
33:1851–1854  
28. Quanhong Han, Yanhua Chu : Combined suture-in-needle and scleral tunnel 
technique for scleral fixation of intraocular lens J Cataract Refract Surg 
2007; 33:1362–1365  
29. Woodhams JT, Lester JC: Pigmentary dispersion glaucoma secondary to 
posterior chamber intraocular lenses. Ann Ophthalmol 16:852, 1984 
30. Smith JP: Pigmentary open-angle glaucoma secondary to posterior chamber 
intraocular lens implantation and erosion of the iris pigment epithelium. Am 
Intraocular Implant Soc J 11:174, 1985 
31.  Huber C: The gray iris syndrome: An iatrogenic form of pigmentary 
glaucoma. Arch Ophthalmol 102:397, 1984 
32.  Samples JR, Van Buskirk EM: Pigmentary glaucoma associated with 
posterior chamber intraocular lenses. Am J Ophthalmol 100:385, 1985 
33. Masket S: Pseudophakic posterior iris chafing syndrome. J Cataract Refract 
Surg 12:252, 1986 
34.  Lieppman ME: Intermittent visual “white out”: A new intraocular lens 
complication. Ophthalmology 89:109, 19 
35. Apple DJ, Reidy JJ, Googe JM, et al: A comparison of ciliary sulcus and 
capsular bag fixation of posterior chamber intraocular lenses. Am Intraocular 
Implant Soc J 11:44, 1985 
36. Anand R, Bowman RW: Simplified technique for suturing dislocated 
posterior chamber intraocular lens to the ciliary sulcus. Arch Ophthalmol 
108:1205, 1990 
37. Solomon K, Gussler JR, Gussler C, Van Meter WS: Incidence of 
management of complications of transsclerally sutured posterior chamber 
lenses. J Cataract Refract Surg 19:488, 1993 
38. Friedberg MA, Berler DK: Scleral fixation of posterior chamber intraocular 
lenses combined with vitrectomy. Ophthalmic Surg 23:18, 1992 
39. Bucci FAJ, Holland EJ, Lindstrom RL: Corneal autografts for external knots 
in transsclerally sutured posterior chamber lenses. Am J Ophthalmol 
112:353, 1991 
40. Lane SS, Lubniewski AJ, Holland EJ: Transsclerally sutured posterior 
chamber lenses: Improved lens designs and techniques to maximize lens 
stability and minimize suture erosion. Semin Ophthalmol 7:245, 1992 
41. Lewis JS: Sulcus fixation without flaps. Ophthalmology 100:1346, 1993 
42. Lindstrom RL, Harris WS: Secondary anterior chamber lens implantation. 
CLAO J 10:133, 1984 
43. Weene LE: Flexible open-loop anterior chamber intraocular lens implants. 
Ophthalmology 100:1636, 1993 
44. Kraff MC, Sanders DR, Lieberman HL, Kraff J: Secondary intraocular lens 
implantation. Ophthalmology 90:324, 1983 
45.  Shammas HJ, Milkie CF: Secondary implantation of anterior chamber 
lenses. Am Intraocular Implant Soc J 9:313, 1983 
46. Cozean CHJ: A longer view of secondary intraocular lens implantation with 
special emphasis on the role of the vitreous. Am Intraocular Implant Soc J 
6:361, 1980 
47. Shammas HJ, Milkie CF: Cystoid macular edema following secondary lens 
implantation. Am Intraocular Implant Soc J 7:40, 1981 
48. Kraff MC, Lieberman HL, Sanders DR: Secondary intraocular lens 
implantation: Rigid/semi-rigid versus flexible lenses. J Cataract Refract Surg 
13:21, 1987 
49. Wong SK, Koch DD, Emery JM: Secondary intraocular lens implantation. J 
Cataract Refract Surg 13:17, 1987 
50. Lyle WA, Jin JC: Secondary intraocular lens implantation: Anterior chamber 
vs. posterior chamber lenses. Ophthal Surg 24:375, 1993 
51. Heller MD, Straatsma BR, Foos RY: Detachment of the posterior vitreous in 
phakic and aphakic eyes. Mod Probl Ophthalmol 10:23, 1972  
52. Menezo JL, Cisneros AL, Cervera M, et al: Iris claw phakic lens: 
Intermediate and long-term corneal endothelial changes. Eur J Implant Ref 
Surg 6:195, 1994  
53.  Menezo JL, Martinez MC, Cisneros AL: Iris-fixated Worst claw versus 
sulcus-fixated posterior chamber lenses in the absence of capsular support. J 
Cataract Refract Surg 22:1476, 1996 
54. Solomon K, Gussler JR, Gussler C, Van Meter WS: Incidence of 
management of complications of transsclerally sutured posterior chamber 
lenses. J Cataract Refract Surg 19:488, 1993 
55. Lubniewski AJ, Holland EJ, Van Meter WS, et al: Histologic study of eyes 
with transsclerally sutured posterior chamber intraocular lenses. Am J 
Ophthalmol 110:237, 1990 
56. Price FWJ, Wellemeyer M: Transscleral fixation of posterior chamber 
intraocular lenses. J Cataract Refract Surg 21:567, 1995 
57. Bleckmann H, Kaczmarek U: Functional results of posterior chamber lens 
implantation with scleral fixation. J Cataract Refract Surg 20:321, 1994 
58. Helal M, El Sayyad F, Elsherif Z, et al: Transscleral fixation of posterior 
chamber intraocular lenses in the absence of capsular support. J Cataract 
Refract Surg 22:347, 1996 
59. Teichmann KD, Teichmann IA: The torque and tilt gamble. J Cataract 
Refract Surg 23:413, 1997 
60. Sharpe MR, Biglan AW, Gerontis CC: Scleral fixation of posterior chamber 
intraocular lenses in children. Ophthalmic Surg Lasers 27:337, 1996 
61. Sivak JG, Kreuzer RO, Hildebrand T: Intraocular lenses, tilt and astigmatism. 
Ophthalmic Res 17:54, 1985 
62. Chang JH, Lee JH. Long-term results of implantation of posterior chamber 
intraocular lens by sulcus fixation. Korean J Ophthalmol 1991;5:42–6. 
63. Menezo JL, Martinez MC, Cisneros AL. Iris-fixated Worst claw versus 
sulcus-fixated posterior chamber lenses in the absence of capsular support. J 
Cataract Refract Surg 1996;22:1476–84. 
64. Helal M, el Sayyad F, Elsherif Z, et al. Transscleral fixation of posterior 
chamber intraocular lenses in the absence of capsular support. J Cataract 
Refract Surg 1996;22:347–51. 
65. McCluskey P, Harrisberg B. Long-term results using  scleral fixated posterior 
chamber intraocular lenses. J Cataract Refract Surg 1994;20:34–9. 
66. Lyle WA, Jin JC. Secondary intraocular lens implantation: anterior chamber 
vs posterior chamber lenses. Ophthalmic Surg 1993;24:375–81. 
67. Bellucci R, Pucci S, Morselli S, Bonomi L. Secondary implantation of angle-
supported anterior chamber and scleralfixated posterior chamber intraocular 
lenses. J Cataract Refract Surg 1996;22:247–52. 
PROFORMA 
 
“MANAGEMENT OF POSTERIOR CAPSULAR TEAR 
WITH SCLERAL FIXATION LENSES” 
A PROSPECTIVE STUDY 
 
1) NAME : 
 
2) AGE:   YEARS  3) SEX: MALE / FEMALE 
 
4) I.P. NO.:    5) MRD. NO. : 
 
6) DATE OF ADMISSION  : 
 
    DATE OF SURGERY   : 
 
    DATE OF DISCHARGE  : 
 
7) ADDRESS: 
 
 
8) EYE INVOLVED   : RIGHT EYE / LEFT EYE 
 
9) PRESENTING COMPLAINTS: 
 
a) Diminution of vision  
  Distant vision  
  Near vision 
b) Duration 
c) Other complaints 
 
10) PAST HISTORY :    (IF YES, DURATION) 
 a) H/O Trauma    : YES/NO 
 b) H/O Congenital anomalies : YES/NO 
 c) H/O Diabetes mellitus  : YES/NO              YRS. 
 d) H/O Hypertension  : YES/NO              YRS. 
 e) H/O Anticoagulant use  : YES/NO 
 f) H/O Congestive cardiac failure : YES/NO             YRS. 
 g) H/O Bronchial asthma  :  YES/NO            YRS. 
 h) H/O Genitourinary symptoms : YES/NO 
 i) Other significant history : 
 
11) PREVIOUS SURGICAL HISTORY: 
 a) Indication : 
 b) Surgical procedure done:  
 c) Duration between first and present surgery : 
 
 
 
12) PREOPERATIVE VISUAL ACUITY (VA) 
 a) UCVA :    b) BCVA : 
d) Type of correction : 
 
 
13) PREOPERATIVE OCULAR EXAMINATION : 
 Facial Symmetry 
    RE   LE 
 Position 
 Extra-ocular movements 
 Eyelids 
 Eyebrows 
 Eyelashes 
 Conjunctiva 
 Cornea 
 Anterior chamber 
 Iris (look for PI) 
 Pupils 
  Size 
  Shape 
  Reaction 
  Synechiae 
 Lens & presence of PC 
 Vitreous 
 Retina 
  Direct  
  Indirect 
  SLB 
 Intraocular pressure 
 Gonioscopy 
 Nasolacrimal duct 
 
 
14) DIAGNOSIS :   RE   LE 
 
15) INVESTIGATIONS : 
 A. Routine: 
  Haemogram 
  CVS 
  RS 
  GIT 
  CNS 
  Others 
  
 B. Ocular 
  IOL Power calculation 
1. K1 reading 
2. K2 reading 
3. Axial length 
4. IOL power (SRK formula) 
 
A scan 
 
B scan 
16) SURGERY 
 a) Name of the operating surgeon: 
 
 b) Anesthesia: 
 
 c) Operative procedure done: 
 
17) PER-OPERATIVE COMPLICATIONS: 
 a) Vitreous hemorrhage 
 b) Globe perforation 
 c) Descemets membrane  tear  
 d) Vitreous loss 
 e) RD 
 f) others 
  
 Management: 
 
18) COMPLICATIONS 24 HRS. POSTOPERATIVE. 
 a) Wound leak 
 b) SK 
 c) Corneal edema 
 d) Hyphema 
 e) A C shallow 
 f) AC flare and cells 
 g) Pupillary capture 
 h) IOL decentration 
 i) ↑ IOP > 30 mm Hg. 
 j) Vitreous hemorrhage 
 
 Management: 
 
19) COMPLICATIONS 1 MONTH POSTOPERATIVELY 
 a) Fibrin 
 b) Corneal edema 
 c) Hyphema 
 d) Anterior uveitis 
 e) Pupillary capture 
 f) IOL decentration 
 g) ↑ IOP > 30 mm Hg. 
 h) Vitreous hemorrhage 
 
 Management: 
 
20) COMPLICATIONS 6 MONTH POSTOPERATIVELY 
 a) Glaucoma 
 b) Pupil deformation 
 c) Persistent uveitis 
 d) CME 
 e) Vitreous prolapse in anterior chamber 
 f) IOL decentration 
 g) IOL surface debris 
 h) PBK 
 i) Suture erosion 
 
 Management: 
 
21) COMPLICATIONS 1 YEAR POSTOPERATIVELY 
 a) Glaucoma 
 b) Pupil deformation 
 c) Persistent uveitis 
 d) CME 
 e) Vitreous prolapse in anterior chamber 
 f) IOL decentration 
 g) IOL surface debris 
 h) PBK 
 i) Suture erosion 
 
 Management: 
 
 
22) FOLLOW-UP AND POSTOPERATIVE BCVA  
 
 a) at 24 hours  : 
 
 b) at 1 month  : 
 
 c) at 6 months : 
 
 d) at 1 year  : 
 
 
23) INFERENCE: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KEY TO MASTER CHART 
 
SEX: 
  M – MALE 
  F – FEMALE 
 
EYE INVOLVED: 
 RE – RIGHT EYE 
 LE – LEFT EYE 
 
PAST HISTORY: 
 T – TRAUMA 
 C – CONGENITAL ANOMALIES 
 D – DIABETES MELLITUS 
 H – HYPERTENSION 
 A – ANTICOAGULANT USE 
 F – CONGESTIVE CARDIAC FAILURE 
 B – BRONCHIAL ASTHMA 
 G – GENITOURINARY ANOMALIES 
 O – OTHERS 
 N – NONE  
 
PRESENTATION: 
 A – APHAKIA 
 C-CATARACT 
SL-SUBLUXATED CATARACTOUS LENS 
 
COMPLICATION PROFILE: 
 SK – STRIATE KERATOPATHY 
 CE – CORNEAL EDEMA 
 HY – HYPHEMA 
 AC – AC FLARE AND CELLS 
 IO – INCREASED IOP 
 AU – ANTERIOR UVEITIS 
 ID – IOL DECENTRATION 
 GL – GLAUCOMA 
 CM – CYSTOID MACULAR EDEMA 
 VH– VITREOUS  HAEMORRHAGE 
 SD – IOL SURFACE DEBRIS 
 SE – SUTURE EROSION 
  
  
 
 
 MASTER CHART. 
S. 
No. 
Age Sex Eye Past 
H/O 
Duration Presentation K1 K2 IOL 
power 
BCVA 
preop 
24 
hrs. 
1 
month 
6 
months 
1 
year 
Compli. 
24 hrs. 
1 
month 
6 
months 
1 year 
1 55 F LE H 6months A 45.75 46.20 +18.00 6/12 6/18 6/12 6/12 6/12 - - - - 
2 60 F RE N - A 44.75 45.00 +26.50 6/6 6/9 6/6 6/6 6/6 AC - - - 
3 60 F RE N - A 42.00 43.20 +23.50 6/24 6/18 6/18 6/18 6/18 SK,AC AU - - 
4 65 F RE N - A 42.70 42.70 +26.50 6/9 6/18 6/9 6/9 6/9 - - - - 
5 70 F RE H 1month A 45.25 48.00 +22.00 6/12 6/18 6/18 6/12 6/12 CE CE - - 
6 48 F LE N - A 45.25 46.25 +26.50 6/18 6/18 6/18 6/12 6/12 AC - - - 
7 70 M LE N - A 42.70 41.50 +21.50 6/12 6/24 6/24 6/24 6/24 CE,VH CE,VH CM CM 
8 44 M RE N - A 40.50. 43.75 +20.50 6/18 6/24 6/24 6/24 6/24 - - - - 
9 55 M RE T 3 years SL 46.00 43.25 +17.50 6/24 6/60 6/60 6/60 6/60 ,AU,IO AU,IO AU,VP AU,VP 
10 60 F RE D 2 years A 44.00 45.25 +22.00 6/24 4/60 6/60 6/60 6/60 VH,AU VH VH CM 
11 65 F RE N - A 44.00 42.25 +26.50 6/12 6/12 6/12 6/12 6/12 AC - - - 
12 75 F RE N - A 48.25 45.25 +21.50 6/12 6/18 6/12 6/12 6/12 - - - - 
13 68 F RE N - A 43.00 43.00 +22.50 6/9 6/9 6/9 6/9 6/9 AC - - - 
14 60 F RE N - A 45.50 45.00 +24.50 6/12 6/12 6/12 6/12 6/12 - - -  
15 65 F RE N - C 46.00 45.00 +23.50 4/60 6/12 6/12 6/9 6/9 SK,AC AU - - 
16 65 F LE N - A 46.20 46.20 +25.50 6/9 6/12 6/12 6/12 6/12 SK,AC -- - - 
17 60 F RE N - A 44.00 41.50 +23.50 6/12 6/18 6/12 6/12 6/12 - - - - 
18 70 F RE N - A 44.50 45.00 +21.50 6/18 6/18 6/18 6/18 6/18 ID ID ID ID 
19 70 M RE D 10 years A 38.20 41.50 +17.50 6/18 6/24 6/18 6/18 6/18 AC AU - - 
20 60 F RE N - C 42.50 43.00 +20.00 6/60 6/12 6/12 6/9 6/9 - - - - 
21 70 M LE N - C 46.50 45.25 +18.00 5/60 6/12 6/12 6/9 6/9 - - -  
22 55 M LE T 1months SL 43.50 44.50 +23.50 1/60 4/60 6/60 6/36 6/36 AU,CE, AU,CE AU, AU, 
23 68 M RE N - A 42.50 40.50 +18.50 6/9 6/9 6/9 6/9 6/9 - - - - 
24 80 F LE D 2years A 44.50 45.25 +20.50 6/12 6/12 6/12 6/12 6/12 - - -  
25 68 M LE N - A 44.00 44.00 +21.00 6/12 6/24 6/24 6/24 6/24 SK.CE CE SD SD 
26 60 F LE N - A 47.50 45.50 +21.00 6/9 6/12 6/12 6/9 6/9 - - - - 
27 79 M LE N - A 44.00 45.00 +20.00 6/9 6/12 6/12 6/12 6/12 - - - - 
28 75 F RE N - A 45.25 45.75 +26.00 6/12 6/12 6/18 6/12 6/12 AC,IO IO - - 
29 70 F RE D 1year A 50.00 47.50 +24.00 6/9 6/12 6/12 6/12 6/12 - - - - 
30 55 M LE N - A 44.75 43.75 +23.50 6/9 6/18 6/12 6/12 6/12 HY,AC  - - 
                   
        
 
 
